Please assess the completion status of the following clinical trial:

Trial Title: B-type Natriuretic Peptide and Glucose Metabolism

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~written informed consent no disease history BNP level within the normal range Normal renal function (serum creatinine of more than 1.3 mg/dL and/or creatinin clearance greater than 80ml/min) Normal ECG~Exclusion Criteria:~systolic blood pressure \< 90 mmHg subjects on any medication abnormal glucose metabolism history of anaphylaxis

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- B-type natriuretic peptide (Type: ACTIVE_COMPARATOR): the effect of B-type natriuretic peptide on glucose metabolism will be compared with placebo during an intravenous glocose tolerance test
- Placebo (Type: PLACEBO_COMPARATOR): comparison of the effect of b-type natriuretic peptide on glucose metabolism and placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).